Similarly, a high level of TAZ mRNA expression was significantly correlated with shorter patient survival in the GSE17538 colon cancer patient cohort (high level: mean survival = 84 months, 95% CI = 72–96 months; low level: mean survival = 109 months, 95% CI = 97–120 months, p = 0.011; Figure 2B). The gene discussed is WWTR1; the disease is colonic neoplasm.